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Journal of Stroke and CWe describe a case of a 34-year-old man with a sudden development of right hemi-
paresis and aphasia because of infarction of the left middle cerebral artery that was
submitted to intravenous (IV) recombinant tissue plasminogen activator and me-
chanical thrombectomy. Transesophageal echocardiogram showed a small mass on
the anterior leaflet of themitral valve. Cardiac surgerywas performed, andhistological
examination of the removedmaterial was consistent with cardiac papillary fibroelas-
toma (CPF). Experience in using IV thrombolysis for the treatment of embolic stroke
because of CPF is limited. To the best of our knowledge, only 3 patients are reported
in literature in whom acute ischemic stroke and associated CPF were treated with
thrombolytic therapy. A discussion of the efficacy of IV thrombolysis and the possible
superiority of mechanical thrombectomy is included. Key Words: Cardiac papillary
fibroelastoma—stroke—thrombolytic therapy—mechanical thrombectomy.
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Cardiac papillary fibroelastoma (CPF) is a rare primary
cardiac tumor, with a significant propensity to embolize.1,2
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erebrovascular Diseases, Vol. -, No. - (--CPF caused cerebral infarction; he was submitted to
intravenous (IV) recombinant tissue plasminogen activator
and mechanical thrombectomy.
Case Report
A 34-year-old man, smoker, was admitted at the emer-
gency room with right hemiparesis, right homonymous
hemianopsia, and mild aphasia of sudden onset (National
Institutes of Health Stroke Scale [NIHSS] 13). Brain com-
puted tomographywas normal. IVrecombinant tissue plas-
minogen activator was started 80 minutes after symptom
onset. By the end of perfusion, NIHSS was 10. At 120 min-
utes after thrombolysis, deterioration occurred (NIHSS 17).
Urgent brain computed tomography excluded hemor-
rhage, and endovascular approach was decided with cere-
bral angiography disclosing a left middle cerebral artery
occlusion (Fig 1). Mechanical clot extractionwas performed
with partial recanalization of the left middle cerebral artery
territory (Fig 1)—symptom recanalization time: 315 min-
utes. At the end of thrombectomy, NIHSS was 20. Brain
magnetic resonance imaging showed only the ischemic in-
farct (Fig 1). Transesophageal echocardiogram revealed), 2013: pp 1-3 1
Figure 1. Cerebral angiography, brain mag-
netic resonance imaging, transesophageal echo-
cardiogram view, and histological examination.
Cerebral angiography showing left M1 middle
cerebral artery occlusion (A). After mechanical
clot extraction, there was partial recanalization
of the left middle cerebral artery territory (B). Ax-
ial T2-weighted turbo spin-echo image showing
an extensive left cortical–subcortical frontotem-
poroparietal hypodensity with extension to the
insula and striatocapsular region (C). Transeso-
phageal echocardiogram revealing a small mass
on the anterior leaflet of the mitral valve, sugges-
tive of cardiac papillary fibroelastoma (D). Histo-
logical examination (hematoxylin–eosin stain,
340) showing a lesion with a papillary configu-
ration lined by flat endocardial cells and with
a densely hyalinized central core (E).
A.F. SANTOS ET AL.2a small mass on the anterior leaflet of the mitral valve, sug-
gestive of CPF (Fig 1). Twenty-eight days after stroke, he
was submitted to cardiac surgery. Histological examination
was consistent with CPF (Fig 1). Clinical evolution was fa-
vorable; however, he remained aphasic, with preserved
comprehension, and hemiparetic (NIHSS 14).Discussion
CPF is a potentially treatable cause of stroke. Tran-
sesophageal echocardiogram is frequently required for
accurate assessment.2 Definite diagnosis is based on histo-
pathological features.1 Because of its rarity, there are few
data regarding safety and efficacy of thrombolytic therapyin acute ischemic strokes caused by CPF. Only 3 previous
reports presented patients with acute ischemic stroke and
associated CPF treated with thrombolytic therapy—1
received alteplase intravenously3 and 2 intra-arteri-
ally4,5—in one of them intra-arterially thrombolysis was
combined with mechanical clot disruption.5 When embo-
lization is from the thrombotic material surrounding the
neoplasm, it could be successfully treated with alteplase;
if the embolizing material is a fragment from the tumor, fi-
brinolytic therapy is probably futile. Patients with known
CPF should not be excluded from receiving alteplase but
as the embolization could originate in the tumor itself, me-
chanical thrombectomy might represent a safe and effec-
tive treatment option. In our case, the clot removed
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examination. But, as its composition can explain the differ-
ences in treatment outcome, we suggest routine histologi-
cal examination for all clots or masses removed during
thrombectomy procedures in acute ischemic stroke.References
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